why choose us

First received: April 09, 2024

Clinical Trial: ERAS for Gastric Cancer Patients After NACT

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gastric Cancer

Study Type: OBSERVATIONAL


Official Title: Short- and Long-term Outcomes Following Perioperative ERAS Management in Patients Undergoing Minimally Invasive Radical Gastrectomy After Neoadjuvant Chemotherapy: A Single-center Retrospective Propen

Brief Summary: Background: Gastric cancer patients receiving neoadjuvant chemotherapy (NACT) are more vulnerable to perioperative stress.Enhanced recovery after surgery (ERAS) is widely used in surgical patients aiming at reducing stress responses.However, whether this approach is safe and feasible for gastric cancer patients received minimally invasive radical gastrectomy after NACT remained determined.So, the objective of this study is to investigate the effects of ERAS for this special group of gastric cancer…

Read more